Cargando…

Role of B‐Type Natriuretic Peptide and N‐Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus

BACKGROUND: Natriuretic peptides are recognized as important predictors of cardiovascular events in patients with heart failure, but less is known about their prognostic importance in patients with acute coronary syndrome. We sought to determine whether B‐type natriuretic peptide (BNP) and N‐termina...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolsk, Emil, Claggett, Brian, Pfeffer, Marc A., Diaz, Rafael, Dickstein, Kenneth, Gerstein, Hertzel C., Lawson, Francesca C., Lewis, Eldrin F., Maggioni, Aldo P., McMurray, John J. V., Probstfield, Jeffrey L., Riddle, Matthew C., Solomon, Scott D., Tardif, Jean‐Claude, Køber, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669146/
https://www.ncbi.nlm.nih.gov/pubmed/28554908
http://dx.doi.org/10.1161/JAHA.116.004743
_version_ 1783275801724059648
author Wolsk, Emil
Claggett, Brian
Pfeffer, Marc A.
Diaz, Rafael
Dickstein, Kenneth
Gerstein, Hertzel C.
Lawson, Francesca C.
Lewis, Eldrin F.
Maggioni, Aldo P.
McMurray, John J. V.
Probstfield, Jeffrey L.
Riddle, Matthew C.
Solomon, Scott D.
Tardif, Jean‐Claude
Køber, Lars
author_facet Wolsk, Emil
Claggett, Brian
Pfeffer, Marc A.
Diaz, Rafael
Dickstein, Kenneth
Gerstein, Hertzel C.
Lawson, Francesca C.
Lewis, Eldrin F.
Maggioni, Aldo P.
McMurray, John J. V.
Probstfield, Jeffrey L.
Riddle, Matthew C.
Solomon, Scott D.
Tardif, Jean‐Claude
Køber, Lars
author_sort Wolsk, Emil
collection PubMed
description BACKGROUND: Natriuretic peptides are recognized as important predictors of cardiovascular events in patients with heart failure, but less is known about their prognostic importance in patients with acute coronary syndrome. We sought to determine whether B‐type natriuretic peptide (BNP) and N‐terminal prohormone B‐type natriuretic peptide (NT‐proBNP) could enhance risk prediction of a broad range of cardiovascular outcomes in patients with acute coronary syndrome and type 2 diabetes mellitus. METHODS AND RESULTS: Patients with a recent acute coronary syndrome and type 2 diabetes mellitus were prospectively enrolled in the ELIXA trial (n=5525, follow‐up time 26 months). Best risk models were constructed from relevant baseline variables with and without BNP/NT‐proBNP. C statistics, Net Reclassification Index, and Integrated Discrimination Index were analyzed to estimate the value of adding BNP or NT‐proBNP to best risk models. Overall, BNP and NT‐proBNP were the most important predictors of all outcomes examined, irrespective of history of heart failure or any prior cardiovascular disease. BNP significantly improved C statistics when added to risk models for each outcome examined, the strongest increments being in death (0.77–0.82, P<0.001), cardiovascular death (0.77–0.83, P<0.001), and heart failure (0.84–0.87, P<0.001). BNP or NT‐proBNP alone predicted death as well as all other variables combined (0.77 versus 0.77). CONCLUSIONS: In patients with a recent acute coronary syndrome and type 2 diabetes mellitus, BNP and NT‐proBNP were powerful predictors of cardiovascular outcomes beyond heart failure and death, ie, were also predictive of MI and stroke. Natriuretic peptides added as much predictive information about death as all other conventional variables combined. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01147250.
format Online
Article
Text
id pubmed-5669146
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56691462017-11-09 Role of B‐Type Natriuretic Peptide and N‐Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus Wolsk, Emil Claggett, Brian Pfeffer, Marc A. Diaz, Rafael Dickstein, Kenneth Gerstein, Hertzel C. Lawson, Francesca C. Lewis, Eldrin F. Maggioni, Aldo P. McMurray, John J. V. Probstfield, Jeffrey L. Riddle, Matthew C. Solomon, Scott D. Tardif, Jean‐Claude Køber, Lars J Am Heart Assoc Original Research BACKGROUND: Natriuretic peptides are recognized as important predictors of cardiovascular events in patients with heart failure, but less is known about their prognostic importance in patients with acute coronary syndrome. We sought to determine whether B‐type natriuretic peptide (BNP) and N‐terminal prohormone B‐type natriuretic peptide (NT‐proBNP) could enhance risk prediction of a broad range of cardiovascular outcomes in patients with acute coronary syndrome and type 2 diabetes mellitus. METHODS AND RESULTS: Patients with a recent acute coronary syndrome and type 2 diabetes mellitus were prospectively enrolled in the ELIXA trial (n=5525, follow‐up time 26 months). Best risk models were constructed from relevant baseline variables with and without BNP/NT‐proBNP. C statistics, Net Reclassification Index, and Integrated Discrimination Index were analyzed to estimate the value of adding BNP or NT‐proBNP to best risk models. Overall, BNP and NT‐proBNP were the most important predictors of all outcomes examined, irrespective of history of heart failure or any prior cardiovascular disease. BNP significantly improved C statistics when added to risk models for each outcome examined, the strongest increments being in death (0.77–0.82, P<0.001), cardiovascular death (0.77–0.83, P<0.001), and heart failure (0.84–0.87, P<0.001). BNP or NT‐proBNP alone predicted death as well as all other variables combined (0.77 versus 0.77). CONCLUSIONS: In patients with a recent acute coronary syndrome and type 2 diabetes mellitus, BNP and NT‐proBNP were powerful predictors of cardiovascular outcomes beyond heart failure and death, ie, were also predictive of MI and stroke. Natriuretic peptides added as much predictive information about death as all other conventional variables combined. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01147250. John Wiley and Sons Inc. 2017-05-29 /pmc/articles/PMC5669146/ /pubmed/28554908 http://dx.doi.org/10.1161/JAHA.116.004743 Text en © 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Wolsk, Emil
Claggett, Brian
Pfeffer, Marc A.
Diaz, Rafael
Dickstein, Kenneth
Gerstein, Hertzel C.
Lawson, Francesca C.
Lewis, Eldrin F.
Maggioni, Aldo P.
McMurray, John J. V.
Probstfield, Jeffrey L.
Riddle, Matthew C.
Solomon, Scott D.
Tardif, Jean‐Claude
Køber, Lars
Role of B‐Type Natriuretic Peptide and N‐Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus
title Role of B‐Type Natriuretic Peptide and N‐Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus
title_full Role of B‐Type Natriuretic Peptide and N‐Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus
title_fullStr Role of B‐Type Natriuretic Peptide and N‐Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus
title_full_unstemmed Role of B‐Type Natriuretic Peptide and N‐Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus
title_short Role of B‐Type Natriuretic Peptide and N‐Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus
title_sort role of b‐type natriuretic peptide and n‐terminal prohormone bnp as predictors of cardiovascular morbidity and mortality in patients with a recent coronary event and type 2 diabetes mellitus
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669146/
https://www.ncbi.nlm.nih.gov/pubmed/28554908
http://dx.doi.org/10.1161/JAHA.116.004743
work_keys_str_mv AT wolskemil roleofbtypenatriureticpeptideandnterminalprohormonebnpaspredictorsofcardiovascularmorbidityandmortalityinpatientswitharecentcoronaryeventandtype2diabetesmellitus
AT claggettbrian roleofbtypenatriureticpeptideandnterminalprohormonebnpaspredictorsofcardiovascularmorbidityandmortalityinpatientswitharecentcoronaryeventandtype2diabetesmellitus
AT pfeffermarca roleofbtypenatriureticpeptideandnterminalprohormonebnpaspredictorsofcardiovascularmorbidityandmortalityinpatientswitharecentcoronaryeventandtype2diabetesmellitus
AT diazrafael roleofbtypenatriureticpeptideandnterminalprohormonebnpaspredictorsofcardiovascularmorbidityandmortalityinpatientswitharecentcoronaryeventandtype2diabetesmellitus
AT dicksteinkenneth roleofbtypenatriureticpeptideandnterminalprohormonebnpaspredictorsofcardiovascularmorbidityandmortalityinpatientswitharecentcoronaryeventandtype2diabetesmellitus
AT gersteinhertzelc roleofbtypenatriureticpeptideandnterminalprohormonebnpaspredictorsofcardiovascularmorbidityandmortalityinpatientswitharecentcoronaryeventandtype2diabetesmellitus
AT lawsonfrancescac roleofbtypenatriureticpeptideandnterminalprohormonebnpaspredictorsofcardiovascularmorbidityandmortalityinpatientswitharecentcoronaryeventandtype2diabetesmellitus
AT lewiseldrinf roleofbtypenatriureticpeptideandnterminalprohormonebnpaspredictorsofcardiovascularmorbidityandmortalityinpatientswitharecentcoronaryeventandtype2diabetesmellitus
AT maggionialdop roleofbtypenatriureticpeptideandnterminalprohormonebnpaspredictorsofcardiovascularmorbidityandmortalityinpatientswitharecentcoronaryeventandtype2diabetesmellitus
AT mcmurrayjohnjv roleofbtypenatriureticpeptideandnterminalprohormonebnpaspredictorsofcardiovascularmorbidityandmortalityinpatientswitharecentcoronaryeventandtype2diabetesmellitus
AT probstfieldjeffreyl roleofbtypenatriureticpeptideandnterminalprohormonebnpaspredictorsofcardiovascularmorbidityandmortalityinpatientswitharecentcoronaryeventandtype2diabetesmellitus
AT riddlematthewc roleofbtypenatriureticpeptideandnterminalprohormonebnpaspredictorsofcardiovascularmorbidityandmortalityinpatientswitharecentcoronaryeventandtype2diabetesmellitus
AT solomonscottd roleofbtypenatriureticpeptideandnterminalprohormonebnpaspredictorsofcardiovascularmorbidityandmortalityinpatientswitharecentcoronaryeventandtype2diabetesmellitus
AT tardifjeanclaude roleofbtypenatriureticpeptideandnterminalprohormonebnpaspredictorsofcardiovascularmorbidityandmortalityinpatientswitharecentcoronaryeventandtype2diabetesmellitus
AT køberlars roleofbtypenatriureticpeptideandnterminalprohormonebnpaspredictorsofcardiovascularmorbidityandmortalityinpatientswitharecentcoronaryeventandtype2diabetesmellitus